|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Impact of Patient Age at Treatment on Outcome Following Radical Retropubic Prostatectomy for Prostate Cancer显示文摘 | Sameer A. Siddiqui Shomik Sengupta Jeffrey M. Slezak Eric J. Bergstralh Bradley C. Leibovich Robert P. Myers Horst Zincke Michael L. Blute | 2006 | The Journal of Urology2006，，3： | 1 |
| 2 | Walk the line: station context, corridor type and bus rapid transit walk access in Jinan, China显示文摘 | Yang Jiang P. Christopher Zegras Shomik Mehndiratta | 2011 | Journal of Transport Geography2011，，1： | 1 |
| 3 | 中央政府在城市交通可持续发展中的角色显示文摘中国城市交通问题已经不仅仅是拥堵、噪音、尾气等地方层面的问题,它涉及宏观经济发展、农田保护、金融体系稳定、能源安全、碳排放等国家甚至国际层面的问题。由于这些溢出问题的存在,中央政府应重新审视其在城市交通方面的作用与职责。对此,世界银行提出,中央政府可从城市交通政策导向、公交发展支持、最佳实践奖励、交通绩效标杆与评估系统、交通投融资体制改革以及城市交通示范项目等方面发挥作用。大力发展高效的公共交通是中国可持续城市交通战略的核心工作,要在有效的商业运营前提下满足社会目标、保证服务质量。保持民营部门与公共部门之间的合作互补关系是中央和地方政府所应共同做出的努力。 | 刘志 Shomik Raj Mehndiratta | 2010 | 城市交通2010，8，5： | 1 |
| 4 | Dietary fiber and colorectal neoplasia显示文摘 | Shomik Sengupta | 2001 | Diseases of the Colon & Rectum2001，，44： | 1 |
| 5 | The Influence of Specific Luminal Factors on the Colonic Epithelium: High-Dose Butyrate and Physical Changes Suppress Early Carcinogenic Events in Rats显示文摘 | Cynthia S. M. Wong Ph.D. Shomik Sengupta M.B.B.S Joe J. Tjandra M.D. F.R.A.C.S. Peter R. Gibson M.D. F.R.A.C.P | 2005 | Diseases of the Colon & Rectum2005，，3： | 1 |
| 6 | Argon plasma coagulation is an effective treatment for refractory hemorrhagic radiation proctitis显示文摘 | Joe J. Tjandra Shomik Sengupta | 2001 | Diseases of the Colon & Rectum2001，，12： | 1 |
| 7 | Local excision of rectal cancer显示文摘 | Shomik Sengupta M.B.B.S. Dr. Joe J. Tjandra M.D | 2001 | Diseases of the Colon & Rectum2001，，9： | 1 |
| 8 | Local excision of rectal cancer显示文摘 | Shomik Sengupta M.B.B.S. Dr. Joe J. Tjandra M.D | 2001 | Diseases of the Colon & Rectum2001，，9： | 1 |
| 9 | Vapor-phase decomposition of dimethyl methylphosphonate (DMMP),a sarin surrogate,in presence of metal oxides显示文摘Chemical warfare agents(CWA)are stockpiled in large quantities across the globe.Agents stored in inaccessible facilities need to be destroyed rapidly without dispersing the compounds to surrounding areas.Metal-based energetic formulations are used in such prompt defeat applications to rapidly decompose the CWA by generating a high temperature environment.An alternate,and possibly a more effective decomposition pathway could be provided by chemicidal action of aerosolized condensed combustion products,which typically consist of metal oxides.Toxic fumes that escape the high temperature blast zone can be neutralized by smoke generated during combustion,depending on the particle size,surface characteristics,chemical properties,and concentration of this smoke.This review considers relevant experimental and modeling studies quantifying decomposition of CWA comprising organophosphorus compounds and their surrogates on the surface of various metal oxides.Dimethyl methylphosphonate(DMMP),a sarine surrogate,was used most commonly for such experiments.Many reported efforts focused on the mechanisms of adsorption of DMMP to various metal oxides and initial reaction steps cleaving various bonds from the chemisorbed molecules.For selected oxides,these experiments were supported by quantum-mechanical calculations.In other studies,the capacity of oxide surfaces to adsorb and decompose DMMP was quantified.In most cases,porous catalysts were used although limited experimental data are available for aerosolized nonporous oxide particles.The reported experimental data applicable to scenarios involving prompt decomposition of CWA are summarized.It is noted that information is lacking describing respective heterogeneous reaction kinetics.Preliminary estimates of aerosolized smoke particle concentrations required to destroy CWA are made considering gas phase diffusion rates and reported values of the oxide capacity to decompose CWA or their surrogates. | Shomik Mukhopadhyay Mirko Schoenitz Edward L.Dreizin | 2021 | Defence Technology(防务技术)2021，17，4： | 0 |
| 10 | Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh’s National Kala-azar Elimination Programme显示文摘Background:Adverse effects of antileishmanial drugs can affect patients’quality of life and adherence to therapy for visceral leishmaniasis(VL)and post-kala-azar dermal leishmaniasis(PKDL).In Bangladesh,there are 26 treatment centers that manage leishmaniasis cases coming from 100 endemic upazilas(subdistricts)of 26 districts(these include VL,PKDL,treatment failure,and relapse VL and cutaneous leishmaniasis cases).This study aimed to investigate the feasibility of using focused pharmacovigilance for VL(VLPV)in Bangladesh’s National Kala-azar Elimination Programme for the early detection and prevention of expected and unexpected adverse drug reactions(ADRs).Methods:This activity has been going on since December 2014.Activity area includes secondary public hospital or Upazila health complex(UHC)in hundred sub districts and Surya Kanta Kala-azar Research Center(SKKRC)in Mymensingh District,a specialized center for management of complicated VL and PKDL cases.Communicable Disease Control(CDC)of the Directorate General of Health Services(DGHS)assigned twenty five of hundred UHCs and SKKRC(total 26)as treatment centers depending on their suitable geographical location.This was implemented for better management of VL cases with Liposomal Amphotericin B(AmBisome®)to ensure patient convenience and proper utilization of this expensive donated drug.A VLPV expert committee and a UHC VLPV team were established,an operational manual and pharmacovigilance report forms were developed,training and refresher training of health personnel took place at UHCs and at the central level,collected information such as patient data including demographics,treatment history and response,adverse events were analyzed.This report includes information for the period from December 2014 to December 2016.Results:From December 2014 to December 2016,1327 leishmaniasis patients were treated and 1066(80%)were available for VLPV.Out of these,57,33,9,and 1%were new VL,PKDL,VL relapse,and other cases,respectively.Liposomal amphotericin B was mostly used(82%)for case management,followed by miltefosine(20%)and paromomycin(3%).Out of the 1066 patients,26%experienced ADRs.The most frequent ADR was fever(17%,176/1066),followed by vomiting(5%,51/1066).Thirteen serious adverse events(SAEs)(eight deaths and five unexpected SAEs)were observed.The expert committee assessed that three of the deaths and all unexpected SAEs were possibly related to treatment.Out of the five unexpected SAEs,four were miltefosine-induced ophthalmic complications and the other was an AmBisome^(■)-induced avascular necrosis of the nasal alae.The Directorate General of the Drug Administration entered the ADRs into the World Health Organization Uppsala Monitoring Centre(WHO-UMC)VigiFlow database.Conclusions:This study found that VLPV through NKEP is feasible and should be continued as a routine activity into the public health system of Bangladesh to ensure patient safety against anti-leishmanial drugs. | Md.Sakhawat Hossain Amresh Kumar A.F.M Akhtar Hossain Md.Mahshin Abhijit Sharma Md.Akter Hossain Varun Sharma Rashidul Haque A.K.M Shamsuzzaman Shomik Maruf Prakash Ghosh Vivek Ahuja Dinesh Mondal | 2018 | Infectious Diseases of Poverty2018，7，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员